Slow Release Intrauterine Insemination als neue Methode der IUI

Maximilian Franz  und Julian Marschalek 

 

  1. Crosignani PG. Intrauterine insemination. ESHRE Capri Workshop Group. Hum Reprod Update. 2009 May-Jun;15(3):265-77
  2. Intrauterine insemination: how many cycles should we perform?, Custers et al, Hum Reprod 2008
  3. Merviel P, Heraud MH, Grenier N, Lourdel E et al. Predictive factors for pregnancy after intrauterine insemination (IUI): an analysis of 1083 cycles an a review of the literature. Fertil Steril 2010 93(1):79-88
  4. Ludwig M. Intrauterine Insemination unter Gonadotropin-Stimulation im GnRH-Antagonisten Protokoll in einem evidezbasierte selektierten Patientenkollektiv. Geb Fra 2004, 64, 1177-1183
  5. Van Voorhis BJ, Barnett M, Sparks AE, Syrop CH, Rosenthal G, Dawson J. Effect of the total motile sperm count on the efficacy and the cost-effectiveness of intrauterine sperm injection and in vitro fertilization. Fertil Steril 2001, 75(4); 661-668 
  6. Dorn C. Inseminationsbehandlung. Aus: Reproduktionsmedizin. Dietrich, Ludwig Griesinger (Hrsg.), Springer Verlag 2013, S. 198-207
  7. Berker B, Kahraman K, Taskin S, Sukur YE, Sonmezer M, Atabekoglu CS. Recombinant FSH versus clomiphene citrate for ovarian stimulation in couples with unexplained infertility and male subfertility undergoing intrauterine insemination: a randomized trial. Arch Gynecol Obstet. 2011 Dec;284(6):1561-6. 
  8. Dovey S1, Sneeringer RM, Penzias AS.Clomiphene citrate and intrauterine insemination: analysis of more than 4100 cycles. Fertil Steril. 2008 Dec;90(6):2281-6.
  9. Cantineau AE, Cohlen BJ, Klip H, Heineman MJ; Dutch IUI Study Group Collaborators. The addition of GnRH antagonists in intrauterine insemination cycles with mild ovarian hyperstimulation does not increase live birth rates--a randomized, double-blinded, placebo-controlled trial. Hum Reprod. 2011 May;26(5):1104-11. 
  10. Veltman-Verhulst SM1, Cohlen BJ, Hughes E, Heineman MJ.  Intra-uterine insemination for unexplained subfertility. Cochrane Database Syst Rev. 2012 Sep 12;9:CD001838.
  11. Berker B, Kahraman K, Taskin S, Sukur YE, Sonmezer M, Atabekoglu CS. Recombinant FSH versus clomiphene citrate for ovarian stimulation in couples with unexplained infertility and male subfertility undergoing intrauterine insemination: a randomized trial. Arch Gynecol Obstet. 2011 Dec;284(6):1561-6. 
  12. Dovey S1, Sneeringer RM, Penzias AS.Clomiphene citrate and intrauterine insemination: analysis of more than 4100 cycles. Fertil Steril. 2008 Dec;90(6):2281-6.
  13. Cantineau AE, Cohlen BJ, Klip H, Heineman MJ; Dutch IUI Study Group Collaborators. The addition of GnRH antagonists in intrauterine insemination cycles with mild ovarian hyperstimulation does not increase live birth rates--a randomized, double-blinded, placebo-controlled trial. Hum Reprod. 2011 May;26(5):1104-11. 
  14. Cantineau AE1, Janssen MJ, Cohlen BJ. Synchronised approach for intrauterine insemination in subfertile couples. Cochrane Database Syst Rev. 2010 Apr 14;(4):CD006942. 
  15. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001502. Intra-uterine insemination versus fallopian tube sperm perfusion for non- tubal infertility. Cantineau AE1, Cohlen BJ, Heineman MJ.
  16. Muharib NS, Abdel Gadir A, Shaw RW. Slow release intrauterine insemination versus the bolus technique in the treatment of women with cervical mucus hostility. Hum Reprod. 1992 Feb;7(2):227-9.

Der Weg bis zur Geburt von Louise Brown.

Henning M. Beier

 

  1. Johnson MH, Franklin SB, Cottingham M, Hopwood N. Why the Medical Research Council refused Robert Edwards and Patrick Steptoe support for research on human conception in 1971. Hum Reprod 2010; 25: 2157-2174.
  2. Edwards RG. An astonishing journey into reproductive genetics since the 1950’s. Reprod Nutr Dev 2005; 45: 299-306.
  3. Fowler RE, Edwards RG. Induction of superovulation and pregnancy in mature mice by gonadotrophins. J Endocrin 1957; 15: 374-384.
  4. Edwards RG, Gates AH. Timing of the stages of the maturation divisions, ovulation, fertilization and the first cleavage of eggs of adult mice treated with gonadotrophins. J Endocrin 1959; 18: 292-304.
  5. Gardner RL, Johnson MH. Bob Edwards and the first decade of Reproductive Biomedicine Online. Reprod Biomed Online 2011; 22: 106-124.
  6. Johnson MH. Robert Edwards: The path to IVF. Reprod Biomed Online 2011; 23: 245-262.
  7. Denver Conference: A proposed standard system of nomenclature of human mitotic chromosomes. Lancet 1960; May 14,1 (7133); 275: 1063-1065.
  8. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292: 154-156.
  9. Edwards RG. IVF and the history of stem cells. Nature 2001; 413: 349-351.
  10. Parkes AS. Off-beat Biologist. The Galton Foundation, Cambridge, UK. 1985.
  11. Austin CR. Observations of the penetration of sperm into the mammalian egg. Austral J Sci Res Series B 1951; 4:581-596.
  12. Chang MC. Fertilizing capacityof spermatozoa deposited into the fallopian tubes. Nature 1951; 168:697-698.
  13. Edwards RG, Bavister BD, Steptoe PC. Early stages of fertilization in vitro of human oocytes matured in vitro. Nature 1969; 221: 632-635.
  14. Beier HM. An eye-opening meeting at Exeter in the summer of 1967. Reprod Biomed Online 2011; 23 (Special Issue 1): 8-9.
  15. Gardner RL, Edwards RG. Control of sex ratio at full term in the rabbit by transferring sexed blastocysts. Nature 1968; 218: 346-349.
  16. Edwards RG, Steptoe PC, Purdy JM. Fertilization and cleavage in vitro of preovulatory human oocytes. Nature 1970; 227: 1307-1309.
  17. Steptoe PC, Edwards RG, Purdy JM. Human blastocysts grown in culture. Nature 1971; 229: 132-133.
  18. Steptoe PC, Edwards RG. Reimplantation of a human embryo with subsequent tubal pregnancy. Lancet 1976; April 24 (7965): 880-882.
  19. Marston JH, Penn R, Sivelle PC. Successful autotransfer of tubal eggs in the rhesus monkey (Macaca mulatta). J Reprod Fert 1977; 49: 175-176.
  20. Edwards RG. Conception in the human female. Academic Press, London, New York, Toronto, Sydney, San Francisco 1980.Transfer and replantation of embryos into recipient females. pp 690-766. 
  21. Edwards RG, Steptoe PC. Birth after the reimplantation of a human embryo. Lancet 1978;312: 366.
  22. Gardner RL. Obituary. Professor Sir Robert Geoffrey Edwards – Nobel Laureate (1925-2013). Reprod Biomed Online 2013; 26: 513-515.
  23. Beier HM. Tribute to Professor Friedrich Seidel on the occasion of his 90th birthday. Hum Reprod 1987; 2: 753-754.
  24. Bennett F. Birth of a journal: a personal memoire. Reprod Biomed Online 2010; 21: 727-728.

Geschlechtsdifferenzierung

Thomas Rabe, Olaf Hiort, Birgit Köhler

 

  1. D Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 1995; 16 (3): 271–321. PMID 7671849.eutscher Ethikrat (2012) Intersexualität-Stellungnahme. Vorsitzender: Prof. Dr. Edzard SchmidtJortzig, Berlin. www.ethikrat.org/dateien/pdf/stellungnahme-intersexualitaet.pdf72
  2. Rey R, Josso N: Sexual Differentiation, www.endotext.org; www.endotext.org/wp-content/uploads/pdfs/sexual-differentiation.pdf; archive.is/3W0jm; 10.9.2013
  3. Ludbrook LM, Bernard P, Bagheri-Fam S, Ryan J, Sekido R, Wilhelm D, Lovell-Badge R, Harley VR. Excess DAX1 leads to XY ovotesticular disorder of sex development (DSD) in mice by inhibiting steroidogenic factor-1 (SF1) activation of the testis enhancer of SRY-box-9 (Sox9). Endocrinology. 2012 Apr;153 (4): 1948–58. doi: 10.1210/en. 2011–1428. Epub 2012 Jan 31.
  4. Hughes IA, Deeb A. Androgen resistance. Best Pract Res Clin Endocrinol Metab 2006; 20 (4): 577–98. doi:10.1016/j.beem. 2006.11.003. PMID 17161333.
  5. Galani A, Kitsiou-Tzeli S, Sofokleous C, Kanavakis E, Kalpini-Mavrou A.  Androgen insensitivity syndrome: clinical features and molecular defects. Hormones 2008; 7 (3): 217–29. PMID 18694860.
  6. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 1995; 16 (3): 271–321. PMID 7671849.
  7. Gottlieb B, Lombroso R, Beitel LK, Trifiro MA. Molecular pathology of the androgen receptor in male (in)fertility. Reprod. Biomed. 2005; Online 10 (1): 42–8. doi:10.1016/S1472-6483(10)60802-4. PMID 15705293.
  8. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 1995; 16 (3): 271–321. PMID 7671849.
  9. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 1995; 16 (3): 271–321. PMID 7671849.
  10. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 1995; 16 (3): 271–321. PMID 7671849.
  11. Galani A, Kitsiou-Tzeli S, Sofokleous C, Kanavakis E, Kalpini-Mavrou A.  Androgen insensitivity syndrome: clinical features and molecular defects. Hormones 2008; 7 (3): 217–29. PMID 18694860.
  12. Hughes IA, Deeb A. Androgen resistance. Best Pract Res Clin Endocrinol Metab 2006; 20 (4): 577–98. doi:10.1016/j.beem.2006.11.003. PMID 17161333.
  13. Gottlieb B, Beitel LK, Trifiro MA. Variable expressivity and mutation databases: The androgen receptor gene mutations database. Hum Mutat 2001; 17 (5): 382–8. doi:10.1002/humu.1113. PMID 11317353.
  14. Ozülker T, Ozpaçaci T, Ozülker F, Ozekici U, Bilgiç R, Mert M. Incidental detection of Sertoli-Leydig cell tumor by FDG PET/CT imaging in a patient with androgen insensitivity syndrome. Ann Nucl Med 2010; 24 (1): 35–9. doi:10.1007/s12149-009-0321-x. PMID 19957213.
  15. Hughes IA, Werner R, Bunch T, Hiort O. Androgen insensitivity syndrome. Semin Reprod Med. 2012 Oct;30(5):432–42.
  16. Störungen der Geschlechtsentwicklung (DSD)
  17. www.kindergynaekologie.de/html/ko¬ra75.htmli. Dr. med. Birgit Köhler aus korasion Nr. 1, Februar 2010
  18. Hughes, I. A., C. Houk, et al. (2006). "Consensus statement on management of intersex disorders." Arch Dis Child 91(7): 554–63.
  19. ghr.nlm.nih.gov/con¬di¬ti¬on/21-hydroxylase-deficiency
  20. Speiser PW, White PC. Congenital Adrenal Hyperplasia. N Engl J Med 2003; 349:776–88.
  21. Dörr H-G, Riepe FG. Adrenogenitales Syndrom. Leitlinien der Gesellschaft für Kinderheilkunde und Jugendmedizin (DGKJ). AWMF online 01/2010,
  22. Nimkarn S, New MI. 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia. Gene Reviews online, , zuletzt gesehen 29.11.2011
  23. The Endocrine Society’s Clinical Guidelines. Congenital Adrenal Hyperplasia Due to Steroid 21-hydroxylase Deficiency: An Endocrine Society Clinical Practic Guideline. The Journal of Clinical Endocrinology & Metabolism 2010; 95 (9): 4133–4160.
  24. Auchus RJ,  Witchel SF,  Leight KR,  Aisenberg J,  Azzizm R,  Bachega TA,  Baker LA,  Baratz AB,  Baskin LS,  Berenbaum SA,  Breault DT,  Cerame BI,  Conway GS,  Eugster EA,  Fracassa S,  Gearhart JP,  Geffner ME,  Harris KB,  Hurwitz RS,  Katz AL,  Kalro BN,  Lee PA,  Lin GA,  Loechner KJ,  Marshall I,  Merke DP,  Migeon CJ,  Miller WL,  Nenadovich TL,  Oberfield SE,  Pass KA,  Poppas DP,  Lloyd-Puryear MA,  Quigley CA,  Riepe FG,  Rink RC,  Rivkees SA,  Sandberg DE,  Schaeffer TL,  Schlussel RN,  Schneck FX,4  Seely EW,  Snyder D,  Speiser PW,  Therrell BL,  VanRyzin C,  Vogiatzi MG,  Wajnrajch MP,  White PC,  Zuckerman AE.  Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative. International Journal of Pediatric Endocrinology 2010, Article ID 275213, doi: 10.1155/2010/275213.
  25. Riepe FG. Nebenniere. Kapitel 24. In: Hiort O, Danne T, Wabitsch M. Pädiatrische Endokrinologie und Diabetologie. Springer Verlag 2010, S. 366–390.
  26. Rabe T, Reisch N, Bettendorf M, Hinderhofer K, Wildt L  Mattle V, Schüring A, Strowitzki T, Albring C  Gemeinsame  Stellungnahme der DGGEF e.V. und des BVF e.V.  Das Adrenogenitale Syndrom bei der Frau.  J. Reproduktionsmed. Endokrinol 2012; 9 (3), 201–224; www.kup.at/kup/pdf/10838.pdf; 11.8.2013
  27. Köhler B, Lin L, Ferraz-de-Souza B, Wieacker P, Heidemann P, Schröder V, Biebermann H, Schnabel D, Grüters A, Achermann JC. Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46,XY patients with severe underandrogenization but without adrenal insufficiency. Hum Mutat. 2008 Jan; 29(1): 59–64.
  28. Meyer-Bahlburg, H. F., C. Dolezal, et al. (2008). "Sexual orientation in women with classical or non-classical congenital adrenal hyperplasia as a function of degree of prenatal androgen excess." Arch Sex Behav 37(1): 85–99.